XML 44 R30.htm IDEA: XBRL DOCUMENT v3.24.3
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK OPTION GRANTED

During the nine months ended September 30, 2024 and 2023, the Company granted options to purchase the number of shares of the Company’s common stock set forth in the table below (in thousands):

 

         
  

Nine months ended

September 30,

 
   2024   2023 
Stock options granted   2,375    237 
SCHEDULE OF WEIGHTED-AVERAGE ASSUMPTIONS USED FOR STOCK OPTIONS GRANTED

The following weighted-average assumptions were used for stock options granted during the nine months ended September 30, 2024 and 2023:

 

         
  

Nine months ended

September 30,

 
   2024   2023 
Weighted average risk-free rate   4.45%   3.82%
Weighted average volatility   97.91%   95.15%
Dividend yield   0.00%   0%
Expected term   5.85 years    5.44 years 
SCHEDULE OF WEIGHTED AVERAGE GRANT-DATE FAIR VALUE OF STOCK OPTIONS

The per-share weighted average grant-date fair value of stock options granted during the nine months ended September 30, 2024 and 2023 were as follows:

 

         
  

Nine months ended

September 30,

 
   2024   2023 
Weighted average grant date fair value  $1.44   $2.99 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

For the three and nine months ended September 30, 2024 and 2023, the Company recognized stock-based compensation expense as follows (in thousands):

 

                 
  

Three months ended

September 30,

  

Nine months ended

September 30,

 
   2024   2023   2024   2023 
Research and development  $13   $57   $74   $177 
General and administrative   392    117    1,036    900 
Total  $405   $174   $1,110   $1,077